Yazar "Cersit, Sinan" seçeneğine göre listele
Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in Turkey(Turkish Soc Cardiology, 2019) Gok, Gulay; Zoghi, Mehdi; Sinan, Umit Yasar; Kilic, Salih; Tokgozoglu, Lale; Sumerkan, Mutlu Cagan; Emren, Volkan; Bekar, Lutfu; Cersit, Sinan; Tunc, Elif; Ulucan, Seref; Altuntas, Emine; Canpolat, Ugur; Ozmen, Namik; Aciksari, Gonul; Dogan, Nazile Bilgin; Gunay, Seyda; Kemaloglu, Meltem Didem; Nacar, Alper Bugra; Karakoyun, Suleyman; Inci, Sinan; Ozlek, Bulent; Aslan, Onur; Baykiz, Derya; Gunduz, Sabahattin; Koroglu, Sedat; Helvaci, Aysen; Coskun, Rasit; Yuksel, Isa Oner; Cetin, Sukru; Yesin, Mahmut; Gursoy, Mustafa Ozan; Enar, Sibel Catirli; Ozturk, Mujgan Tek; Yilmaz, Aykut; Basaran, Ozcan; Okyay, Kaan; Ozturk, Cengiz; Celik, Oguzhan; Yalcinkaya, Emre; Aslan, Vedat; Senol, Utku; Ucar, Fatih Mehmet; Kozluca, Volkan; Turkoglu, Ebru Ipek; Sekuri, Cevat; Erturk, Mehmet; Altun, Ibrahim; Belen, Erdal; Aksan, Gokhan; Yildirim, Erkan; Sayin, Ahmet; Akkoyun, Dursun Cayan; Tuncez, Abdullah; Dogan, Volkan; Gurel, Yusuf Emre; Demirelli, Selami; Koca, Cigdem; Biteker, Murat; Bas, Hasan Aydin; Guzet, Feza; Tacoy, Gulten; Alpsoy, Seref; Turan, Turhan; Davutoglu, Vedat; Birdane, Alparslan; Onrat, Ersel; Baha, Mehmet Resat; Yilmaz, Sabiye; Altay, Servet; Alici, Mehmet Hayri; Ozcan, Ismail Turkay; Kus, Gorkem; Demir, Gultekin Gunhan; Sancar, Kadriye Memic; Demircelik, Muhammed Bora; Yanik, Ahmet; Akciger, Atike Nazli; Hoscan, Yesim; Arslan, Kursat; Otlu, Yilmaz Omur; Sahin, Ismail; Ersoy, Ibrahim; Yilmaz, Dilek Cicek; Mert, Kadir Ugur; Varim, Perihan; Ari, HatemObjective: Heart failure (HF) has a high prevalence and mortality rate in elderly patients; however, there are few studies that have focused on patients older than 80 years. The aim of this study is to describe and compare the age-specific demographics and clinical features of Turkish elderly patients with HF who were admitted to cardiology clinics. Methods: The Epidemiology of Cardiovascular Disease in Elderly Turkish population (ELDER-TURK) study was conducted in 73 centers in Turkey, and it recruited a total of 5694 patients aged 65 years or older. In this study, the clinical profile of the patients who were aged 80 years or older and those between 65 and 79 years with HF were described and compared based on the ejection fraction (EF)-related classification: HFrEF and HFpEF (is considered as EF: >= 50%). Results: A total of 1098 patients (male, 47.5%; mean age, 83.5 +/- 3.1 years) aged 80 years and 4596 patients (male, 50.2 %; mean age, 71.1 +/- 4.31 years) aged 65-79 years were enrolled in this study. The prevalence of HF was 39.8% for patients who were >= 80 years and 27.1% for patients 65-79 years old. For patients aged >= 80 years with HF, the prevalence rate was 67% for hypertension (HT), 25.6% for diabetes mellitus (DM), 54.3% for coronary artery disease (CAD), and 42.3% for atrial fibrilation. Female proportion was lower in the HFrEF group (p=0.019). The prevalence of HT and DM was higher in the HFpEF group (p<0.01), whereas CAD had a higher prevalence in the HFrEF group (p=0.02). Among patients aged 65-79 years, 43.9% (548) had HFpEF, and 56.1% (700) had HFrEF. In this group of patients aged 65-79 years with HFrEF, the prevalence of DM was significantly higher than in patients aged >= 80 years with HFrEF (p<0.01). Conclusion: HF is common in elderly Turkish population, and its frequency increases significantly with age. Females, diabetics, and hypertensives are more likely to have HFpEF, whereas CAD patients are more likely to have HFrEF.Öğe Secondary prevention of coronary heart disease in elderly population of Turkey: A subgroup analysis of ELDERTURK study(Via Medica, 2019) Kilic, Salih; Sumerkan, Mutlu Cagan; Emren, Volkan; Bekar, Lutfu; Cersit, Sinan; Tunc, Elif; Gok, Gulay; Altuntae, Emine; Canpolat, Ugur; Sinan, Umit Yasar; Ozmen, Namik; Zoghi, MehdiBackground: Secondary prevention plays an important role after acute coronary event due to high risk of adverse events in elderly. In present study we aimed to evaluate the lifestyle, management of risk factors and medical treatment for secondary protection in elderly patients with known coronary heart disease (CHD). Methods: ELDERTURK is a non-interventional, multi-centered, observational study, which included total of 5694 elderly patients (>65 years) from 50 centers in Turkey. In this study elderly patients from the ELDERTURK population with known CHD were evaluated for cardiovascular risk factors, comorbidities and medication usage. Results: A total of 2976 (52.3% of study) out of 5694 patients included in the ELDERTURK study were evaluated. All had known CHD with a mean age of 73.4 +/- 6.2 years and 60.3% were male. 13.0% of patients were smokers, 42.4% were overweight and 21.1% were obese. Only 23.6% of patients reported to do regular exercise, 73.4% had history of hypertension, 47.4% had dyslipidemia and 33.9% had diabetes mellitus. The rate of patients with systolic blood pressure > 140 mmHg were 31.1% and only 13.9% of patients had a recommended <= 70 mg/dL level of low-density lipoprotein cholesterol. Antiplatelet, statin, beta-blocker and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker usage was limited to 27.3%. Conclusions: The ELDERTURK study shows that many patients with CHD have a high prevalence of modifiable risk factors and unhealthy lifestyle. Apart from this, many patients are not receiving therapeutic intervention and as a consequence most were not achieving the recommended goals.